Source link : https://www.newshealth.biz/health-news/makers-of-sickle-cell-disease-gene-therapy-to-participate-in-payment-model-cms-says/
Vertex Pharmaceuticals and bluebird bio have entered into an agreement with CMS to participate in a new Medicaid payment model for gene-based sickle cell anemia treatments, the agency announced Wednesday. “The Cell and Gene Therapy Access Model will increase access to promising therapies that improve the chances of people living longer, healthier lives,” CMS Administrator […]
Author : News Health
Publish date : 2024-12-04 20:22:10
Copyright for syndicated content belongs to the linked Source.